On March 15, FDA posted new and revised versions of the following Import Alerts on the detention without physical examination of:

FDA’s ongoing policy of enforcement discretion for food facilities that have co-manufacturing agreements with brand owners and must comply with certain Food Safety Modernization Act requirements for supply-chain programs will remain in effect until further notice, while the agency considers its enforcement approach, including by way of a potential new rule.

On March 14, FDA posted new and revised versions of the following Import Alerts on the detention without physical examination of:

On March 11, FDA posted new and revised versions of the following Import Alerts on the detention without physical examination of:

On March 10, FDA posted new and revised versions of the following Import Alerts on the detention without physical examination of:

On March 9, FDA posted new and revised versions of the following Import Alerts on the detention without physical examination of:

FDA has issued its Enforcement Report for March 9, listing the status of recalls and field corrections for food, cosmetics, tobacco products, drugs, biologics and devices. The report covers both domestic and foreign firms.

On March 8, FDA posted new and revised versions of the following Import Alerts on the detention without physical examination of:

On March 7, FDA posted new and revised versions of the following Import Alerts on the detention without physical examination of:

A new import alert recently issued by FDA on imported foods contaminated by filth “provides the agency with a pathway for regulatory action on entries that are violative for filth and not subject to any of the more specific filth related” import alerts, an FDA spokesperson said by email March 8. “Previous alerts were for very specific products and/or countries. In addition to refusing individual shipments, the agency can now apply Detention Without Physical Examination to a broad range of filth related issues,” the spokesperson said.